UNSPSC 51263128: Nipradilol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C15H22N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FVM336I71Y, chemically known as 3,4-dihydro-8-(2-hydroxy-3-isopropylamino)propoxy-3-nitroxy-2h-1-benzopyran but generally known as nipradilol, which bears US NIH Compound Identifier 72006. European Medicines Agency schedules Nipradilol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12423MIG.

UNSPSC 51263128 Nipradilol is a Commodity code for a specific pharmaceutical product, but state and local procurement activity under this code shows a significant mismatch with the pharmaceutical scope. The single recent opportunity tagged to this code—Seminole County, Florida's IFB60459723LAS—actually solicits Naloxone and drug deactivation systems, which fall outside the Nipradilol category entirely. Naloxone is an opioid antagonist used for overdose reversal, and drug deactivation systems are harm-reduction infrastructure; neither aligns with Nipradilol, a cardiac medication. This tagging discrepancy suggests either a data entry error in the county's procurement system or a misclassification by the source aggregator.

Seminole County's IFB, posted June 30, 2026 with a response deadline of July 26, 2023, seeks annual procurement of 1,900 units of Naloxone and 800 safe drug deactivation systems through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term plus one optional renewal year, fixed-fee pricing, and potential FEMA funding. Vendors must provide unit costs for each line item, comply with drug-free workplace and E-Verify requirements, maintain workers' compensation and commercial general liability insurance, and accept a three-month probationary period with termination-at-will provisions. No explicit set-asides for disadvantaged enterprises are specified. Given the single recent opportunity and the fundamental mismatch between the Nipradilol commodity definition and the actual procurement, this code shows no reliable activity signal for pharmaceutical suppliers pursuing state and local contracts in this category.